EGF Theramed Health Corp.
CSE: TMED, OTC: EVAHF, FFT: AUHP
Company Overview
EGF Theramed Health Corp. is focused on improving delivery systems and creating a strong intellectual property portfolio around psilocybin.
The company has two companies in its portfolio:
- Pharmadelic Labs is a biotech company focused on improving and patenting engineering processes for the biosynthesis of compounds with a focus on psilocybin. EGF Theramed owns a 30% stake in Pharmadelic Labs.
- Green Parrot Labs is a Caribbean-based company focused on psilocybin research and building a network of health centers dealing with treatment-resistant conditions—piggybacking on established medical tourism trends. EGF Theramed owns a 40% stake in Green Parrot Labs.
Financial Highlights
$0
Revenue (ttm)
-$577,007
Gross Profit (ttm)
-$0.05
Diluted EPS (ttm)
Management Team
Mr. Jatinder Dhaliwal
CEO & Director
Mr. Usama Chaudhry
CFO & Director
Mr. Brendan Purdy L.L.D.
Interim Chief Operating Officer of the Medical Blockchain & Data Security Division
Key Highlights
Market Capitalization
$1,080,035
Shares Outstanding
18,452,766
Shares Short (% of Float)
9,445 (0%)
Insider Ownership
4%